Head-to-head · WeighScore
AVARA Rx vs BiltRx
By GLP-1 ScorecardUpdated
Score comparison
BiltRx has the higher recorded score — 75.3/100 to 62.8/100.
BiltRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BiltRx is a US health-optimization telehealth platform spanning men's health, women's health, aesthetics and weight loss that offers compounded and brand-name GLP-1 medications.
Before you choose
Before comparing the headline prices, the AVARA Rx review and the BiltRx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, AVARA Rx vs CoreAge Rx and BiltRx vs BioGlow Health compare each of them with another graded program, and the list of alternatives to AVARA Rx ranks the programs closest to AVARA Rx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the System Labs review covers one graded close to these two, at 68.4/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | AVARA Rx | BiltRx |
|---|---|---|
| WeighScore | 62.8/100 | 75.3/100 |
| Grade | C | C |
| Site position | #285 | #59 |
| Semaglutide | Personalized "GLP-1" (drug not named) starting at $229 | $82/mo advertised medication starting price; confirm care and shipping charges |
| Tirzepatide | Personalized "GLP-1/GIP" (drug not named) starting at $279 | $130/mo advertised medication starting price; confirm care and shipping charges |
| Coverage | All 50 states | All 50 states advertised |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Names its pharmacy partner (DiRx Health, Ft Lauderdale FL) — buyers can independently verify its licensure
- Names its clinical network (Beluga Health) — you can research the platform handling your prescriptions
- All 50 states explicitly listed on the FAQ — uncommon vs peers that just say 'nationwide'
- Patient-friendly refunds — full refund if a provider disqualifies you, partial if a weaker dose is prescribed
- LegitScript verification badge displayed; pharmacy claims NABP-accredited facilities
What to consider
- Operating legal entity not disclosed — only a Sheridan, WY registered-agent-style address surfaced
- Dose pricing not itemized — only 'starting at $229' for GLP-1 and 'starting at $279' for GLP-1/GIP, without naming either drug
- LegitScript certification number not shown — badge only, so no direct lookup
- No named medical director (Beluga Health is the network, not a named MD)
- Lab work requirements not specified, and consultation fee not broken out from medication cost
Strengths
- Publishes 12-week package totals
- Explains the consultation charge if treatment is declined
What to consider
- Confirm whether consultation and shipping are included in the selected plan
- Renewal cancellation does not refund an approved order
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.